Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2009 (Event Date)
Reporting Date: January 14, 2009
Context: The company reported receiving notice from NYSE Alternext US LLC (formerly AMEX) regarding the intention to delist its common stock due to noncompliance with specific listing standards.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. However, it cites the following financial thresholds as the basis for the delisting notice:
- Stockholders' Equity: Reported as less than $6,000,000 (triggering Section 1003(a)(iii) given sustained net losses in the five most recent fiscal years).
- Stockholders' Equity: Reported as less than $4,000,000 (triggering Section 1003(a)(ii) given sustained net losses in three of the four most recent fiscal years).
- Share Price: Described as selling for a substantial period at a low price per share (triggering Section 1003(f)(v)).
Material Changes
The primary material change is the impending delisting of Nephros, Inc. common stock from NYSE Alternext US LLC. The company announced it will not appeal the delisting decision due to turmoil in the capital markets. Instead, the company has identified a market maker to apply for registration and quotation on the OTC Bulletin Board, expected to be effective immediately following the delisting.
Outlook, Risks, and Management Commentary
- Delisting Timeline: The delisting from AMEX is expected to be effective in the first half of February 2009.
- Market Transition: Trading is expected to move to the OTC Bulletin Board.
- Management Decision: Management explicitly decided against seeking an appeal of the delisting.
- Risks: The filing highlights noncompliance with equity and share price standards, indicating ongoing financial distress characterized by sustained net losses.
Investor Verification Checklist
- Verify the exact date of delisting from NYSE Alternext US LLC (expected first half of February 2009).
- Confirm the ticker symbol and trading status on the OTC Bulletin Board once the transition occurs.
- Review the most recent audited financial statements to confirm the specific stockholders' equity balance and net loss history cited in the delisting notice.
- Assess the liquidity impact of moving from a national exchange to the OTC Bulletin Board.